Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer.
Clin Med Insights Oncol
; 17: 11795549231187264, 2023.
Article
in En
| MEDLINE
| ID: mdl-37528890
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Med Insights Oncol
Year:
2023
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States